Dr. Jörg Schickert
If you work in the pharma, medical devices or biotech sector, it is Jörg Schickert who will be solving all your most complicated regulatory, commercial and compliance issues – for both Germany and all of Europe. His long-standing experience in dealing with German and European pharmaceutical and devices law means that he can circumspectly navigate you through all your reimbursement or pricing & reimbursement challenges. He will also aid you in drafting commercial/licensing contracts. Furthermore, you may turn to him with any most delicate criminal and compliance cases which your company might face. Jörg is very practical and always offers business-oriented solutions. He takes his industry knowledge from 15 years' experience in working hand-in-hand with many major and reputed life sciences companies.
Jörg is one of the few go-to lawyers in Europe for complex issues in the core business of the life sciences industry. He has a deep knowledge across all relevant legal areas of the day-to-day business of selling pharmaceutical products and devices or offering health solutions. This allows him to provide overall solutions for issues and projects which have implications in very different legal disciplines, such as regulatory, reimbursement, commercial, and compliance. He advises on reimbursement strategies, clinical trials, the launch and marketing of new products, dealing with healthcare professionals, anti-corruption/transparency, product safety and vigilance and related agreements and contracts. He also assists our corporate teams in transactions pertaining to the life science industry. Most recently, his life sciences industry team won the 'Life Sciences Practice of the Year' Award from JUVE, LMG and Best Lawyers – all in one year.
One client pinpoints his efforts to "really understand the client's needs" as a key strength, while another describes him as "particularly responsive and accountable."
Jörg Schickert has "outstanding expertise in restitution law", is "very experienced in contract negotiations" and "meets the most stringent demands".
Advising a leading pharmaceutical company on its innovative approach regarding digital health offerings in 21 countries on 4 continents.
Advising a U.S. medical devices company on regulatory and commercial issues regarding the market launch of a gene test in 24 European countries.
Advising Baxter regarding the regulatory and commercial law aspects of the sale and transfer of its renal replacement business to Nikkiso in 29 countries.
Advising several pharmaceutical and medical devices companies on their HCP compliance under German anti-bribery laws.
Advising MorphoSys AG in drafting and negotiating a worldwide licence and collaboration agreement with Emergent Biosolutions re the joint development of an antibody.
Advising a leading U.S. biotech company on the HTA assessment before the German Federal Joint Committee (G-BA) and its strategy during price negotiations.
Recommended lawyer for pharmaceutical and medical device law
Jörg Schickert has "very broad industry knowledge" and "is incredibly well versed in the EU law".
Legal 500 Germany
Recommended as top lawyer for Health Care Law, Regulatory Practice and Pharmaceuticals Law
Best Lawyers Germany
Jörg Schickert has been recognised as Life Sciences Europe Star for Regulatory and for Finance & Transactional
LMG Life Sciences
Recommended lawyer for Regulatory – Life Sciences and Transactional – Life Sciences
Who's Who Legal
Leading lawyer for legal regulation in the health sector
Legal 500 Germany
Clients praise the "very successful cooperation" with the team led by Dr. Jörg Schickert. They highlight in particular the "flexible and creative solutions".
Recommended lawyer for Regulatory and for Financial & Transactional
LMG Life Sciences